Communiqués TransMedics Group, Inc.

Actions

TMDX

US89377M1099

Equipement et technologie médicale avancés

Temps réel estimé Cboe BZX 19:42:52 27/08/2026			Varia. 5j.	Varia. 1 janv.
93,32 ^USD	+1,20%		+2,20%	-23,68%

05/08	TransMedics Group, Inc. : UBS confirme sa recommandation neutre	ZM
05/08	Transcript : TransMedics Group, Inc., Q2 2026 Earnings Call, Aug 04, 2026

Communiqués

17/08	TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX	BU
11/08	TransMedics : Canaccord Genuity 46th Annual Growth Conference Presentation	PU
05/08	TransMedics : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
05/08	TransMedics : Second Quarter 2026 Earnings Presentation	PU
04/08	TransMedics: Q2 Earnings Snapshot	AQ
04/08	TransMedics Reports Second Quarter 2026 Financial Results	PR
03/08	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	PR
21/07	TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026	PR
06/07	TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH	PR
03/06	TransMedics : William Blair 2026 Presentation	PU
21/05	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	PR
19/05	TransMedics to Present at the William Blair 46th Annual Growth Stock Conference	PR
06/05	TransMedics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
06/05	TransMedics : First Quarter 2026 Earnings Presentation	PU
05/05	TransMedics: Q1 Earnings Snapshot	AQ
05/05	TransMedics Reports First Quarter 2026 Financial Results	PR
29/04	TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH	PR
23/04	TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting	PR
21/04	TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026	PR
27/02	TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results	PR
24/02	TransMedics : Fourth Quarter 2025 Earnings Presentation	PU
24/02	TransMedics: Q4 Earnings Snapshot	AQ
24/02	TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results	PR
23/02	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	AQ
20/02	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	PR